Is Buying BAYER AG ORDINARY SHARES (OTCMKTS:BAYZF), Having Higher Short Interest a Winning Strategy?

May 17, 2018 - By Karen Cook

Bayer Aktiengesellschaft (OTCMKTS:BAYZF) Logo

The stock of BAYER AG ORDINARY SHARES (OTCMKTS:BAYZF) registered an increase of 3.05% in short interest. BAYZF’s total short interest was 1.00M shares in May as published by FINRA. Its up 3.05% from 973,000 shares, reported previously. With 3,400 shares average volume, it will take short sellers 295 days to cover their BAYZF’s short positions.

It closed at $122.65 lastly. It is down 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Bayer Aktiengesellschaft operates as a life science firm worldwide. The company has market cap of $108.33 billion. The firm operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro divisions. It has a 11.9 P/E ratio. The Pharmaceuticals segment offers prescription products primarily for cardiology and womenÂ’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: